Morgan Stanley analyst Thibault Boutherin raised the firm’s price target on Sandoz (SDZNY) to CHF 41 from CHF 35 and keeps an Equal Weight rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SDZNY:
- Sandoz downgraded to Neutral from Buy at UBS
- Sandoz price target raised to CHF 41 from CHF 39 at Berenberg
- FDA adds boxed warning to Teva’s Copaxone for allergic reaction
- M&A News: Intra-Cellular Stock Rallies 36% on News of $14.6B Acquisition by Johnson & Johnson
- Intra-Cellular price target raised to $118 from $100 at BofA